Literature DB >> 27707967

Neuronal Dystroglycan Is Necessary for Formation and Maintenance of Functional CCK-Positive Basket Cell Terminals on Pyramidal Cells.

Simon Früh1, Jennifer Romanos1, Patrizia Panzanelli2, Daniela Bürgisser3, Shiva K Tyagarajan1, Kevin P Campbell4, Mirko Santello1, Jean-Marc Fritschy5.   

Abstract

Distinct types of GABAergic interneurons target different subcellular domains of pyramidal cells, thereby shaping pyramidal cell activity patterns. Whether the presynaptic heterogeneity of GABAergic innervation is mirrored by specific postsynaptic factors is largely unexplored. Here we show that dystroglycan, a protein responsible for the majority of congenital muscular dystrophies when dysfunctional, has a function at postsynaptic sites restricted to a subset of GABAergic interneurons. Conditional deletion of Dag1, encoding dystroglycan, in pyramidal cells caused loss of CCK-positive basket cell terminals in hippocampus and neocortex. PV-positive basket cell terminals were unaffected in mutant mice, demonstrating interneuron subtype-specific function of dystroglycan. Loss of dystroglycan in pyramidal cells had little influence on clustering of other GABAergic postsynaptic proteins and of glutamatergic synaptic proteins. CCK-positive terminals were not established at P21 in the absence of dystroglycan and were markedly reduced when dystroglycan was ablated in adult mice, suggesting a role for dystroglycan in both formation and maintenance of CCK-positive terminals. The necessity of neuronal dystroglycan for functional innervation by CCK-positive basket cell axon terminals was confirmed by reduced frequency of inhibitory events in pyramidal cells of dystroglycan-deficient mice and further corroborated by the inefficiency of carbachol to increase IPSC frequency in these cells. Finally, neurexin binding seems dispensable for dystroglycan function because knock-in mice expressing binding-deficient T190M dystroglycan displayed normal CCK-positive terminals. Together, we describe a novel function of dystroglycan in interneuron subtype-specific trans-synaptic signaling, revealing correlation of presynaptic and postsynaptic molecular diversity. SIGNIFICANCE STATEMENT: Dystroglycan, an extracellular and transmembrane protein of the dystrophin-glycoprotein complex, is at the center of molecular studies of muscular dystrophies. Although its synaptic distribution in cortical brain regions is long established, function of dystroglycan in the synapse remained obscure. Using mice that selectively lack neuronal dystroglycan, we provide evidence that a subset of GABAergic interneurons requires dystroglycan for formation and maintenance of axonal terminals on pyramidal cells. As such, dystroglycan is the first postsynaptic GABAergic protein for which an interneuron terminal-specific function could be shown. Our findings also offer a new perspective on the mechanisms that lead to intellectual disability in muscular dystrophies without associated brain malformations.
Copyright © 2016 the authors 0270-6474/16/3610297-18$15.00/0.

Entities:  

Keywords:  GABA; cholecystokinin; dystroglycanopathy; dystrophin-glycoprotein complex; interneurons; perisomatic

Mesh:

Substances:

Year:  2016        PMID: 27707967      PMCID: PMC6705590          DOI: 10.1523/JNEUROSCI.1823-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  35 in total

1.  Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex.

Authors:  H Yamada; F Saito; H Fukuta-Ohi; D Zhong; A Hase; K Arai; A Okuyama; R Maekawa; T Shimizu; K Matsumura
Journal:  Hum Mol Genet       Date:  2001-07-15       Impact factor: 6.150

2.  GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin.

Authors:  Ina Brünig; Anthi Suter; Irene Knuesel; Bernhard Lüscher; Jean-Marc Fritschy
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

3.  Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat.

Authors:  G Nyíri; T F Freund; P Somogyi
Journal:  Eur J Neurosci       Date:  2001-02       Impact factor: 3.386

4.  Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice).

Authors:  I Knuesel; M Mastrocola; R A Zuellig; B Bornhauser; M C Schaub; J M Fritschy
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

Review 5.  Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?

Authors:  Leszek Kaczmarek; Joanna Lapinska-Dzwonek; Sylwia Szymczak
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

6.  Synaptic scaffolding molecule (S-SCAM) membrane-associated guanylate kinase with inverted organization (MAGI)-2 is associated with cell adhesion molecules at inhibitory synapses in rat hippocampal neurons.

Authors:  Kazutaka Sumita; Yuji Sato; Junko Iida; Akira Kawata; Mamiko Hamano; Susumu Hirabayashi; Kikuo Ohno; Elior Peles; Yutaka Hata
Journal:  J Neurochem       Date:  2006-10-24       Impact factor: 5.372

7.  Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons.

Authors:  Martin K-H Schäfer; Hélène Varoqui; Norah Defamie; Eberhard Weihe; Jeffrey D Erickson
Journal:  J Biol Chem       Date:  2002-10-15       Impact factor: 5.157

8.  Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation.

Authors:  Sabine Lévi; R Mark Grady; Michael D Henry; Kevin P Campbell; Joshua R Sanes; Ann Marie Craig
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

9.  A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of alpha-dystroglycan.

Authors:  Pervin Dinçer; Burcu Balci; Yeliz Yuva; Beril Talim; Martin Brockington; Deniz Dinçel; Silvia Torelli; Sue Brown; Gülsev Kale; Göknur Haliloglu; Filiz Ozbas Gerçeker; Rengül Cetin Atalay; Cengiz Yakicier; Cheryl Longman; Francesco Muntoni; Haluk Topaloglu
Journal:  Neuromuscul Disord       Date:  2003-12       Impact factor: 4.296

10.  A stoichiometric complex of neurexins and dystroglycan in brain.

Authors:  S Sugita; F Saito; J Tang; J Satz; K Campbell; T C Südhof
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  26 in total

Review 1.  Establishment and Maintenance of Neural Circuit Architecture.

Authors:  Emily L Heckman; Chris Q Doe
Journal:  J Neurosci       Date:  2021-02-10       Impact factor: 6.167

2.  Generation of dystrophin short product-specific tag-insertion mouse: distinct Dp71 glycoprotein complexes at inhibitory postsynapse and glia limitans.

Authors:  Takahiro Fujimoto; Takeshi Yaoi; Kenta Nakano; Tetsuya Arai; Tadashi Okamura; Kyoko Itoh
Journal:  Cell Mol Life Sci       Date:  2022-01-30       Impact factor: 9.261

3.  Integrins Bidirectionally Regulate the Efficacy of Inhibitory Synaptic Transmission and Control GABAergic Plasticity.

Authors:  Grzegorz Wiera; Patrycja Brzdąk; Anna Maria Lech; Katarzyna Lebida; Jadwiga Jabłońska; Przemysław Gmerek; Jerzy W Mozrzymas
Journal:  J Neurosci       Date:  2022-06-14       Impact factor: 6.709

Review 4.  Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits.

Authors:  Thomas C Südhof
Journal:  Cell       Date:  2017-11-02       Impact factor: 41.582

5.  Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development.

Authors:  Reena Clements; Rolf Turk; Kevin P Campbell; Kevin M Wright
Journal:  J Neurosci       Date:  2017-07-31       Impact factor: 6.167

6.  Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets.

Authors:  Max Lam; Joey W Trampush; Jin Yu; Emma Knowles; Gail Davies; David C Liewald; John M Starr; Srdjan Djurovic; Ingrid Melle; Kjetil Sundet; Andrea Christoforou; Ivar Reinvang; Pamela DeRosse; Astri J Lundervold; Vidar M Steen; Thomas Espeseth; Katri Räikkönen; Elisabeth Widen; Aarno Palotie; Johan G Eriksson; Ina Giegling; Bettina Konte; Panos Roussos; Stella Giakoumaki; Katherine E Burdick; Antony Payton; William Ollier; Ornit Chiba-Falek; Deborah K Attix; Anna C Need; Elizabeth T Cirulli; Aristotle N Voineskos; Nikos C Stefanis; Dimitrios Avramopoulos; Alex Hatzimanolis; Dan E Arking; Nikolaos Smyrnis; Robert M Bilder; Nelson A Freimer; Tyrone D Cannon; Edythe London; Russell A Poldrack; Fred W Sabb; Eliza Congdon; Emily Drabant Conley; Matthew A Scult; Dwight Dickinson; Richard E Straub; Gary Donohoe; Derek Morris; Aiden Corvin; Michael Gill; Ahmad R Hariri; Daniel R Weinberger; Neil Pendleton; Panos Bitsios; Dan Rujescu; Jari Lahti; Stephanie Le Hellard; Matthew C Keller; Ole A Andreassen; Ian J Deary; David C Glahn; Anil K Malhotra; Todd Lencz
Journal:  Cell Rep       Date:  2017-11-28       Impact factor: 9.995

7.  Postnatal Gene Therapy Improves Spatial Learning Despite the Presence of Neuronal Ectopia in a Model of Neuronal Migration Disorder.

Authors:  Huaiyu Hu; Yu Liu; Kevin Bampoe; Yonglin He; Miao Yu
Journal:  Genes (Basel)       Date:  2016-11-29       Impact factor: 4.096

8.  Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Azeez Aranmolate; Nathaniel Tse; Holly Colognato
Journal:  BMC Neurosci       Date:  2017-08-14       Impact factor: 3.288

Review 9.  Assembly and maintenance of GABAergic and Glycinergic circuits in the mammalian nervous system.

Authors:  Clare R Gamlin; Wan-Qing Yu; Rachel O L Wong; Mrinalini Hoon
Journal:  Neural Dev       Date:  2018-06-07       Impact factor: 3.842

Review 10.  Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders.

Authors:  Rachel Ali Rodriguez; Christina Joya; Rochelle M Hines
Journal:  Front Mol Neurosci       Date:  2018-04-24       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.